HC Wainwright Affirms Buy Rating on Lineage Cell Therapeutics Inc. (LCTX) amid Type 1 Diabetes Push
Lineage Cell Therapeutics Inc. (NYSE:LCTX) is one of the best performing penny stocks to buy now.
Lineage Cell Therapeutics Inc. (LCTX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Kapitalo Investimentos Jo„O Carlos Pinho And Carlos Woelz | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 0 | $0.00 | 49,560,992 | 2025-01-27 | Filing | |
| $0.76 | 7,894,737 | $6,000,000.12 | 49,560,992 | 2025-01-27 | Filing | |
| $0.59 | 15,000 | $8,850.00 | 25,500 | 2024-11-26 | Filing | |
| $0.60 | 15,000 | $9,000.00 | 22,184 | 2024-11-26 | Filing | |
| $0.57 | 40,000 | $22,640.00 | 298,555 | 2024-11-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.44 | 28,445 | $69,405.80 | 0 | 2021-12-29 | Filing | |
| $2.49 | 9,250 | $23,032.50 | 28,445 | 2021-12-29 | Filing | |
| $2.45 | 501,588 | $1,228,890.60 | 28,445 | 2021-12-28 | Filing | |
| $2.93 | 19,142 | $56,086.06 | 15,578 | 2021-06-29 | Filing | |
| $2.97 | 4,720 | $14,018.40 | 87,500 | 2021-06-29 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,006,930 | $15,221,712 | 0% | |
| 2. | 511,363 | $864,203 | 0.73% | |
| 3. | 218,274 | $368,883 | 0% | |
| 4. | 98,370 | $166,245 | 0% | |
| 5. | 47,050 | $79,515 | 0% |
News See All
10 Best Performing Penny Stocks to Buy Now
Long-lagging small-cap and penny stocks are increasingly capturing the attention of value investors.
Lineage Cell Therapeutics, Inc. (LCTX) Shows Vision Gains in Phase 1/2a OpRegen Trial
Lineage Cell Therapeutics, Inc. (NYSE:LCTX) is a clinical-stage biotech company developing allogeneic “off-the-shelf” cell therapies for neurological and ophthalmic disorders.
15 Best Biotech Penny Stocks to Invest in Right Now
Jared Holz, the healthcare strategist for Mizuho, spoke on CNBC's "Closing Bell Overtime" in July on whether the biotech industry is ready for a breakthrough.
Brad Gerstner Portfolio: Top 7 New Stock Picks
Strategists and investors are confident that the new administration will fuel the state of mergers and acquisitions in the United States.
Billionaire Ken Fisher and Corporate Insiders Are Buying These 10 Stocks
In this article, we will take a detailed look at Billionaire Ken Fisher and Corporate Insiders Are Buying These 10 Stocks.
Top 10 Growth Stocks in Biotech
The biotech industry encompasses a wide range of fields, including genetic engineering, biomanufacturing, bioinformatics, and synthetic biology.
5 Best Biotech Penny Stocks To Buy Now
In this article, we will be taking a look at the 5 best biotech penny stocks to buy now.
10 Best One Dollar Stocks To Buy Now
In this article, we discuss the 10 best one dollar stocks to buy now.
10 Best Penny Stocks to Buy in July
Penny stocks are priced under $5 and often represent high-risk public companies that do offer exponential growth potential.